Search Results

You are looking at 1 - 10 of 31 items for :

  • "immunotherapy" x
Clear All
Janice Ser Huey Tan Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Janice Ser Huey Tan in
Google Scholar
PubMed
Close
,
Timothy Kwang Yong Tay Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Timothy Kwang Yong Tay in
Google Scholar
PubMed
Close
,
Enya Hui Wen Ong Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Enya Hui Wen Ong in
Google Scholar
PubMed
Close
,
Michael Fehlings ImmunoScape, 1 Scotts Road #24-10, Singapore

Search for other papers by Michael Fehlings in
Google Scholar
PubMed
Close
,
Daniel Shao-Weng Tan Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Daniel Shao-Weng Tan in
Google Scholar
PubMed
Close
,
Nadiah Binte Sukma Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Nadiah Binte Sukma in
Google Scholar
PubMed
Close
,
Eileen Xueqin Chen Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Eileen Xueqin Chen in
Google Scholar
PubMed
Close
,
Jen-Hwei Sng Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Jen-Hwei Sng in
Google Scholar
PubMed
Close
,
Connie Siew Poh Yip Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Connie Siew Poh Yip in
Google Scholar
PubMed
Close
,
Kok Hing Lim Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Kok Hing Lim in
Google Scholar
PubMed
Close
,
Darren Wan-Teck Lim Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Darren Wan-Teck Lim in
Google Scholar
PubMed
Close
,
Narayanan Gopalakrishna Iyer Division of Surgical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Narayanan Gopalakrishna Iyer in
Google Scholar
PubMed
Close
,
Jacqueline Siok Gek Hwang Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Jacqueline Siok Gek Hwang in
Google Scholar
PubMed
Close
,
Melvin Lee Kiang Chua Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Melvin Lee Kiang Chua in
Google Scholar
PubMed
Close
, and
Mei-Kim Ang Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Mei-Kim Ang in
Google Scholar
PubMed
Close

methods Patient selection Consecutive patients with newly diagnosed ATC at a single institution with ECOG ≤2, adequate organ function, no active autoimmune disease and contraindications to immunotherapy were included. Diagnosis and pathology of all

Open access
Alessandro Brancatella Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Close
,
Laura Pierotti Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Laura Pierotti in
Google Scholar
PubMed
Close
,
Nicola Viola Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Nicola Viola in
Google Scholar
PubMed
Close
,
Isabella Lupi Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Close
,
Lucia Montanelli Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Close
,
Chiara Cremolini Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Search for other papers by Chiara Cremolini in
Google Scholar
PubMed
Close
,
Paolo Piaggi Department of Information Engineering, University of Pisa, Pisa, Italy

Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Close
,
Antonio Chella Pneumology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Search for other papers by Antonio Chella in
Google Scholar
PubMed
Close
,
Andrea Antonuzzo Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Search for other papers by Andrea Antonuzzo in
Google Scholar
PubMed
Close
,
Daniele Sgrò Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Daniele Sgrò in
Google Scholar
PubMed
Close
,
Lucia Antonangeli Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lucia Antonangeli in
Google Scholar
PubMed
Close
,
Chiara Sardella Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Close
,
Sandra Brogioni Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Close
,
Claudio Marcocci Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Close
,
Ferruccio Santini Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
Close
, and
Francesco Latrofa Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Close

(i.e. subacute thyroiditis and type 2 amiodarone-induced thyrotoxicosis) ( 9 , 10 ), recent guidelines and expert opinion recommend no treatment for the destructive forms induced by immunotherapy, since data in this setting are lacking ( 3 , 11

Open access
Alan Chun Hong Lee Division of Endocrinology and Metabolism, Department of Medicine, Queen Mary Hospital, Hong Kong, China
Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Close
and
George J. Kahaly Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Close

]. ATX-GD-59 Rationale and Mechanisms of Actions. Antigen-specific immunotherapy is an effective treatment for common allergic conditions, especially atopy (allergic rhinitis/conjunctivitis, asthma, atopic dermatitis) and stinging insect

Free access
Junyu Tong Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Junyu Tong in
Google Scholar
PubMed
Close
,
Maomei Ruan Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China

Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Close
,
Yuchen Jin Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Close
,
Hao Fu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Hao Fu in
Google Scholar
PubMed
Close
,
Lin Cheng Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Lin Cheng in
Google Scholar
PubMed
Close
,
Qiong Luo Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Qiong Luo in
Google Scholar
PubMed
Close
,
Zhiyan Liu Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Close
,
Zhongwei Lv Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China

Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Close
, and
Libo Chen Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China

Search for other papers by Libo Chen in
Google Scholar
PubMed
Close

therapy, differentiation therapy, and immunotherapy are primarily used for thyroid carcinomas poorly controlled by traditional treatment, although most of the relevant researches remain ongoing. Molecular targeted therapy Inhibiting angiogenesis and

Open access
Susanne Neumann Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Susanne Neumann in
Google Scholar
PubMed
Close
,
Christine C. Krieger Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Christine C. Krieger in
Google Scholar
PubMed
Close
, and
Marvin C. Gershengorn Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda, Bethesda, Maryland, USA

Search for other papers by Marvin C. Gershengorn in
Google Scholar
PubMed
Close

’s clinical activity score and exophthalmos was observed [ 24 ]. K1–70 is a promising treatment option and currently in phase I clinical trials (https://Clinical Trials.gov/show/NCT02904330) [ 25 ]. Recently, antigen-specific immunotherapies have been

Free access
Earn H. Gan Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Earn H. Gan in
Google Scholar
PubMed
Close
,
Anna L. Mitchell Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Anna L. Mitchell in
Google Scholar
PubMed
Close
,
Ruth Plummer Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Ruth Plummer in
Google Scholar
PubMed
Close
,
Simon Pearce Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Simon Pearce in
Google Scholar
PubMed
Close
, and
Petros Perros Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom

Search for other papers by Petros Perros in
Google Scholar
PubMed
Close

What Is Known about This Topic? Anti-CTLA-4 immunotherapy used in cancer treatment can cause thyroiditis and Graves disease. What Does This Case Report Add? Transient thyroiditis and Graves disease usually take place within

Free access
Jaume Capdevila Vall d’Hebron University Hospital, Vall d’Hebron Institute of Oncology (VHIO), IOB Quiron-Teknon, Barcelona, Spain

Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Close
,
Desiree’ Deandreis Department of Medical Sciences, Nuclear Medicine Unit, University of Turin, AOU Città della Salute e della Scienza, Turin, Italy

Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Close
,
Cosimo Durante Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy

Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Close
,
Sophie Leboulleux Service of Endocrinology, Diabetology, University Hospital Geneve, Geneve, Switzerland

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Close
,
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed
Close
,
Romana Netea-Maier Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands

Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Close
,
Kate Newbold Royal Marsden Hospital, London, United Kingdom

Search for other papers by Kate Newbold in
Google Scholar
PubMed
Close
,
Susanne Singer Institute of Medical Biostatistics Epidemiology and Informatics (IMBEI), University Medical Center of Johannes Gutenberg University, Mainz, Germany

Search for other papers by Susanne Singer in
Google Scholar
PubMed
Close
,
Gerasimos P Sykiotis Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Close
,
Beate Bartes Association “Vivre sans Thyroïde”, Léguevin, France

Search for other papers by Beate Bartes in
Google Scholar
PubMed
Close
,
Kate Farnell Butterfly Thyroid Cancer Trust, Rowlands Gill, Tyne & Wear, UK

Search for other papers by Kate Farnell in
Google Scholar
PubMed
Close
, and
Laura Deborah Locati Medical Oncology Unit, IRCCS ICS Maugeri, Pavia, Italy
Department of Internal Medicine and Therapeutics, University of Pavia, Italy

Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Close

patients with DTC treated with lenvatinib. Even though the therapeutic landscape in RAI-R DTC is evolving, with new targeted therapies, immunotherapy, etc., lenvatinib is expected to remain a first-line treatment and mainstay of therapy for several years in

Open access
Pauline Campredon Department of Endocrinology and Metabolic Diseases, Larrey University Hospital, Toulouse, France

Search for other papers by Pauline Campredon in
Google Scholar
PubMed
Close
,
Philippe Imbert Ophthalmologist, Clinique du Parc, Toulouse, France
Multidisciplinary Thyroid Eye Consultation, Department of Endocrinology, Larrey University Hospital, Toulouse, France

Search for other papers by Philippe Imbert in
Google Scholar
PubMed
Close
,
Céline Mouly Department of Endocrinology and Metabolic Diseases, Larrey University Hospital, Toulouse, France

Search for other papers by Céline Mouly in
Google Scholar
PubMed
Close
,
Solange Grunenwald Department of Endocrinology and Metabolic Diseases, Larrey University Hospital, Toulouse, France

Search for other papers by Solange Grunenwald in
Google Scholar
PubMed
Close
,
Julien Mazières Department of Pneumology, Larrey University Hospital, Toulouse, France

Search for other papers by Julien Mazières in
Google Scholar
PubMed
Close
, and
Philippe Caron Department of Endocrinology and Metabolic Diseases, Larrey University Hospital, Toulouse, France

Search for other papers by Philippe Caron in
Google Scholar
PubMed
Close

What Is Known about This Topic? Anti-PD-1 monoclonal antibody therapy is associated with immune-related adverse events, and the most frequent is inflammatory thyroiditis. During immunotherapy, immune-related ocular toxicities are

Free access
Hippolyte Dupuis Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Hippolyte Dupuis in
Google Scholar
PubMed
Close
,
Emilie Merlen Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France

Search for other papers by Emilie Merlen in
Google Scholar
PubMed
Close
,
Arnaud Jannin Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Arnaud Jannin in
Google Scholar
PubMed
Close
,
Philippe Jamme University of Lille, Lille, France
Department of Dermatology, Lille University Hospital, Lille, France

Search for other papers by Philippe Jamme in
Google Scholar
PubMed
Close
,
Alexandre Fagart Department of Nuclear Medicine, Valenciennes Hospital Center, Valenciennes, France

Search for other papers by Alexandre Fagart in
Google Scholar
PubMed
Close
,
Marie-Christine Vantyghem Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed
Close
, and
Miriam Ladsous Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France

Search for other papers by Miriam Ladsous in
Google Scholar
PubMed
Close

.1056/NEJMoa1709030 ) 2 Antonelli A Ferrari SM Fallahi P . Current and future immunotherapies for thyroid cancer . Expert Review of Anticancer Therapy 2018 18 149 – 159 . ( https://doi.org/10.1080/14737140.2018.1417845 ) 3 Illouz F Drui D Caron

Open access
Alessandro Brancatella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Close
,
Nicola Viola Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Nicola Viola in
Google Scholar
PubMed
Close
,
Sandra Brogioni Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Close
,
Lucia Montanelli Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Close
,
Chiara Sardella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Close
,
Paolo Vitti Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Close
,
Claudio Marcocci Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Close
,
Isabella Lupi Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Close
, and
Francesco Latrofa Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Close

autoimmune hyperthyroidism and Graves’ ophthalmopathy. Of note, euthyroid Graves’ ophthalmopathy is very uncommon after other immunotherapy drugs (e.g., interferon and alemtuzumab); in these settings, ophthalmopathy is usually associated with hyperthyroidism

Free access